CARACTERIZAÇÃO DA RESPOSTA IMUNOLÓGICA DE PACIENTES COM GLIOBLASTOMA IDH WILDTYPE ATENDIDOS NO HOSPITAL LUXEMBURGO

Authors

DOI:

https://doi.org/10.61229/mpj.v2i1.41

Keywords:

Glioblastoma IDH-wildtype, imuno checkpoints, imuno-histoquímica

Abstract

Glioblastoma (GBM) is a malignant tumor of the central nervous system with a high mortality rate, characterized by necrosis and vascular proliferation. This study evaluates the immune response in patients with GBM, focusing on immunosuppression mediated by the interaction between PDL-1 and PD-1. Patients from Hospital Luxemburgo will have tumor samples analyzed by immunohistochemistry for various immune markers. It is expected that characterizing the immune response will reveal evasion mechanisms in the tumor microenvironment and identify targets for new therapies, contributing to the development of immunotherapies that improve treatment and patient quality of life.

Downloads

Download data is not yet available.

Author Biographies

Matheus Bortolini Lima Muniz , Faculty of Minas Gerais- FAMINAS-BH

Acadêmico do curso de Medicina, FAMINAS-BH, Faculdade de Minas Gerais 

Leonardo Augusto Wendling Henriques, Luxemburgo Hospital

PhD in Neurosurgery , neurosurgeon at Luxemburgo Hospital of Mário Penna Institute. 

Paulo Guilherme de Oliveira Salles, Mário Penna Institute

PhD, Pathologist at Hospital Luxemburgo and Scientific Director at the Teaching, Research and Innovation Center of the Mário Penna Institute.

izabela Ferreira Gontijo de Amorim , Faculty of Minas Gerais- FAMINAS-BH and Mario Penna Institute

PhD, Professor of Medicine at the Faculdade de Minas Gerais - FAMINAS and Researcher at the Teaching, Research and Innovation Center of the Mário Penna Institute.

Letícia da conceição Braga , Mário Penna Institute

PhD, Translational Research Manager at the Mário Penna Institute.

References

Dapash M, Hou D, Castro B, Lee-Chang C, Lesniak MS. The Interplay between Glioblastoma and Its Microenvironment. Cells. 2021; 10(9):2257. doi: 10.3390/cells10092257. PMID: 34571905; PMCID: PMC8469987. DOI: https://doi.org/10.3390/cells10092257

Pointer KB, Clark PA, Schroeder AB, Salamat MS, Eliceiri KW, Kuo JS. Association of collagen architecture with glioblastoma patient survival. J Neurosurg. 2017 Jun;126(6):1812-1821. doi: 10.3171/2016.6.JNS152797. Epub 2016. PMID: 27588592; PMCID: PMC5386834. DOI: https://doi.org/10.3171/2016.6.JNS152797

Hoogstrate Y, Draaisma K, Ghisai SA, van Hijfte L, Barin N, de Heer I, et al. Transcriptome analysis reveals tumor microenvironment changes in glioblastoma. Cancer Cell. 2023; 41(4):678-692.e7. doi: 10.1016/j.ccell.2023.02.019. Epub 2023 Mar 9. PMID: 36898379. DOI: https://doi.org/10.1016/j.ccell.2023.02.019

Published

2024-08-16

How to Cite

Bortolini Lima Muniz , M., Wendling Henriques, L. A., de Oliveira Salles, P. G., Ferreira Gontijo de Amorim , izabela, da conceição Braga , L., & Alencar, R. (2024). CARACTERIZAÇÃO DA RESPOSTA IMUNOLÓGICA DE PACIENTES COM GLIOBLASTOMA IDH WILDTYPE ATENDIDOS NO HOSPITAL LUXEMBURGO . Mário Penna Journal, 2(1), 112–114. https://doi.org/10.61229/mpj.v2i1.41

Most read articles by the same author(s)

1 2 > >>